Pharma analytics that deliver real-world insight
Our life sciences products offer the fastest and most precise way to query +300M payer-complete longitudinal care journeys for actionable insights.
Clarify Trials
Will I recruit enough patients for my protocol and who are the best site investigators to select?
Clarify Portfolio
How big is the addressable market and did I make the right pricing and uptake assumptions?
Clarify Growth
Which patients are most likely to meet our label and which HCP are mostly likely to prescribe the therapy?
Clarify drives demonstrable impact for commercial teams
60%
More patients with a rare heart condition were identified by uncovering patients who were most likely mis-diagnosed
3x
More scripts of a rare disease treatment were written by HCPs that Clarify scored as high-opportunity
7k
Patients identified at high risk of non-adherence to infusion therapy by using social determinants of health data
Life sciences analytics, queryable in seconds
Clarify Growth
Enhance your brand’s launch and in-market performance with our real-world commercial analytics. They extract the micro-level detail you need to compete differently. You can sub-segment patients by any inclusion and exclusion criteria, rank HCP based on therapy-specific factors, and track share versus your competitors at the patient segment level.
Clarify Portfolio
Whether you are assessing the potential of a partnership deal or exploring a new market opportunity, this analytics software gives you the inputs you need to gauge true value, in seconds. Using its self-service capabilities, you can build precise cohorts, slice and dice them by clinical and non-clinical characteristics, and understand treating HCPs.
Clarify Trials
Evaluating your protocol against real-world data can go a long way to ensuring you can recruit the right patients to meet your study endpoints. Our advanced analytics software is configurable to any therapeutic area, and lets you optimize your protocol based on real-world patient eligibility and advanced scoring of site investigators.
Pfizer and Clarify talk data strategies for commercialization
Pfizer and Clarify Health sat down with HLTH to talk about creating data-driven value stories for new therapies. Hear what Bhash Parasuraman, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer and Manisha Gulati, Chief Operating Officer, Clarify Health have to say.
